Name | Number of supported studies | Average coverage | |
---|---|---|---|
secretory cell | 10 studies | 33% ± 19% | |
club cell | 9 studies | 45% ± 13% | |
mesothelial cell | 9 studies | 44% ± 19% | |
type I pneumocyte | 7 studies | 28% ± 14% | |
basal cell | 7 studies | 39% ± 14% | |
epithelial cell | 7 studies | 28% ± 11% | |
respiratory goblet cell | 4 studies | 50% ± 20% | |
mucus secreting cell | 4 studies | 64% ± 28% | |
keratinocyte | 4 studies | 28% ± 8% | |
squamous epithelial cell | 3 studies | 54% ± 15% | |
luminal cell of prostate epithelium | 3 studies | 41% ± 7% | |
brush cell | 3 studies | 31% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 27% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 81% | 3142.45 | 199 / 245 | 84% | 185.55 | 421 / 502 |
pancreas | 68% | 1191.77 | 224 / 328 | 76% | 55.75 | 136 / 178 |
esophagus | 39% | 5674.24 | 559 / 1445 | 64% | 54.25 | 118 / 183 |
stomach | 75% | 3955.37 | 268 / 359 | 23% | 12.47 | 66 / 286 |
ovary | 1% | 15.12 | 2 / 180 | 87% | 97.84 | 374 / 430 |
lung | 46% | 751.47 | 268 / 578 | 40% | 29.48 | 457 / 1155 |
skin | 72% | 9018.48 | 1294 / 1809 | 8% | 3.98 | 37 / 472 |
uterus | 4% | 254.06 | 6 / 170 | 44% | 40.37 | 201 / 459 |
tonsil | 0% | 0 | 0 / 0 | 44% | 27.26 | 20 / 45 |
thymus | 0% | 0 | 0 / 653 | 42% | 31.65 | 256 / 605 |
breast | 17% | 594.84 | 80 / 459 | 17% | 17.88 | 194 / 1118 |
intestine | 0% | 1.29 | 1 / 966 | 32% | 17.32 | 171 / 527 |
adipose | 24% | 587.17 | 287 / 1204 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 16% | 9.85 | 80 / 504 |
liver | 0% | 0 | 0 / 226 | 7% | 4.81 | 28 / 406 |
adrenal gland | 0% | 0 | 0 / 258 | 1% | 2.35 | 2 / 230 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.20 | 7 / 901 |
heart | 1% | 8.89 | 6 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 8.15 | 4 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 4.10 | 2 / 803 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0.15 | 1 / 705 |
peripheral blood | 0% | 4.27 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006508 | Biological process | proteolysis |
GO_0005615 | Cellular component | extracellular space |
GO_0030141 | Cellular component | secretory granule |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0008236 | Molecular function | serine-type peptidase activity |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | KLK11 |
Protein name | Kallikrein-11 (hK11) (EC 3.4.21.-) (Hippostasin) (Serine protease 20) (Trypsin-like protease) [Cleaved into: Kallikrein-11 inactive chain 1; Kallikrein-11 inactive chain 2] Kallikrein-related peptidase 11 transcript variant 6 Kallikrein related peptidase 11 |
Synonyms | PRSS20 UNQ649/PRO1279 TLSP |
Description | FUNCTION: Possible multifunctional protease. Efficiently cleaves 'bz-Phe-Arg-4-methylcoumaryl-7-amide', a kallikrein substrate, and weakly cleaves other substrates for kallikrein and trypsin. Cleaves synthetic peptides after arginine but not lysine residues. . |
Accessions | M0R151 M0QYW4 ENST00000593681.5 ENST00000319756.7 ENST00000453757.8 [Q9UBX7-1] ENST00000598799.5 ENST00000600362.5 A0A2I4PZK7 A0A0A0MR55 ENST00000391804.7 [Q9UBX7-4] ENST00000601671.1 ENST00000594768.5 [Q9UBX7-2] Q9UBX7 ENST00000319720.11 [Q9UBX7-1] M0QZV0 M0QZI8 |